Publications by authors named "Ralph Shapiro"

Claim this Profile
E
Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies.
Elena E Perez, Jacques Hébert, Anne K Ellis, Oral Alpan, William R Lumry, Ralph Shapiro

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema.
Anna Valerieva, Maria Staevska, Milos Jesenak, Katarina Hrubiskova, Marta Sobotkova, Ralph Shapiro

J Allergy Clin Immunol Pract· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients.
Paula Busse, James Baker, Inmaculada Martinez-Saguer, Jonathan A Bernstein, Timothy Craig, Ralph Shapiro

J Allergy Clin Immunol Pract· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An essential role for the Zn transporter ZIP7 in B cell development.
Consuelo Anzilotti, David J Swan, Bertrand Boisson, Mukta Deobagkar-Lele, Catarina Oliveira, Ralph S Shapiro

Nat Immunol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial.
Aleena Banerji, Marc A Riedl, Jonathan A Bernstein, Marco Cicardi, Hilary J Longhurst, Ralph Shapiro

JAMA· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and validation of a novel disease-specific quality-of-life instrument for patients with primary antibody deficiency disease (PADQOL-16).
Mark Ballow, Mark R Conaway, Panida Sriaroon, Rima A Rachid, Filiz O Seeborg, Ralph Shapiro

J Allergy Clin Immunol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema.
Timothy Craig, Ralph Shapiro, Arthur Vegh, James W Baker, Jonathan A Bernstein

Allergy Rhinol (Providence)· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Paradigm of Primary Immunodeficiency Disease: Individualizing Immunoglobulin Dose and Delivery to Enhance Outcomes.
Ralph S Shapiro, Richard L Wasserman, Vincent Bonagura, Sudhir Gupta

J Clin Immunol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supplement: Frontiers in Immunoglobulin Therapy of Primary Immunodeficiency Disease.
Ralph S Shapiro

J Clin Immunol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Studies.
Ralph S Shapiro, Richard L Wasserman, Vincent Bonagura, Sudhir Gupta

J Clin Immunol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registry.
Markus Magerl, Michael Frank, William Lumry, Jonathan Bernstein, Paula Busse, Ralph Shapiro

Ann Allergy Asthma Immunol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Training hereditary angioedema patients to self-administer intravenous C1 esterase inhibitor concentrate.
Ralph S Shapiro, Lisa Zacek

J Infus Nurs· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facilitating home-based treatment of hereditary angioedema.
Jonathan A Bernstein, Marc Riedl, Lisa Zacek, Ralph S Shapiro

Allergy Asthma Proc· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous immunoglobulin therapy given by subcutaneous rapid push vs infusion pump: a retrospective analysis.
Ralph S Shapiro

Ann Allergy Asthma Immunol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics.
Ralph S Shapiro

Pediatr Allergy Immunol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical ambiguities--ongoing questions.
Troy R Torgerson, Vincent R Bonagura, Ralph S Shapiro

J Clin Immunol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why I use subcutaneous immunoglobulin (SCIG).
Ralph S Shapiro

J Clin Immunol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved IgG3 levels and reduced infection rate in a woman with CVID switched from intravenous to subcutaneous immunoglobulin therapy.
Ralph S Shapiro

Immunotherapy· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local and national advocacy support.
Ralph S Shapiro, Marcia Boyle, Elena E Perez

J Clin Immunol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Payor issues: barriers to optimal management of patients with primary immunodeficiency.
Ralph S Shapiro, Marcia Boyle

J Clin Immunol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defective nuclear IKKα function in patients with ectodermal dysplasia with immune deficiency.
Stephane T Temmerman, Chi A Ma, Yongge Zhao, Jeffrey Keenan, Ivona Aksentijevich, Ralph Shapiro

J Clin Invest· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignancies in the setting of primary immunodeficiency: Implications for hematologists/oncologists.
Ralph S Shapiro

Am J Hematol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A custom 148 gene-based resequencing chip and the SNP explorer software: new tools to study antibody deficiency.
Hong-Ying Wang, Vivek Gopalan, Ivona Aksentijevich, Meredith Yeager, Chi Adrian Ma, Ralph Shapiro

Hum Mutat· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous immunoglobulin therapy by rapid push is preferred to infusion by pump: a retrospective analysis.
Ralph Shapiro

J Clin Immunol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis